Median Technologies SA (EPA:ALMDT)

Market Cap	152.02M +65.7%
Revenue (ttm)	23.38M +4.8%
Net Income	-21.99M
EPS	-1.16
Shares Out	36.72M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	558,695
Average Volume	332,113
Open	4.310
Previous Close	4.325
Day's Range	3.980 - 4.325
52-Week Range	1.192 - 4.890
Beta	0.65
RSI	48.17
Earnings Date	Apr 23, 2026

About Median Technologies

Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnostic tests based on imaging for the diagnosis and treatment of patients suffering from cancer; and iCRO, a central imaging service and AI-powered Imagin...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 211
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMDT

Financial Performance

In 2024, Median Technologies's revenue was 22.96 million, an increase of 0.79% compared to the previous year's 22.78 million. Losses were -25.24 million, 9.83% more than in 2023.